Role of galectin-3 in genital tract immunosuppression
Role of galectin-3 in genital tract immunosuppression
批准号:
7260284
负责人:
ALAN B DIEKMAN
金额:
$23.04万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-05 至 2009-05-31
关键词:
AIDS preventionAdhesionsAffinityAntibodiesBindingBinding ProteinsBiochemicalBiological AssayCarbohydratesCell AdhesionCell CommunicationCo-ImmunoprecipitationsColumn ChromatographyDataExhibitsFamily memberFemaleFlow CytometryFluorescence MicroscopyFutureGalactose Binding LectinGalactosidesGalectin 3Genital systemGoalsHIVHIV InfectionsHealthHeterosexualsHumanImmune systemImmunityImmunoelectron MicroscopyImmunosuppressionImmunosuppressive AgentsInfectionInvestigationLaboratoriesLactoseLectinLeukocytesLigand BindingLigandsMediatingMembraneMolecularNatural ImmunityPathogenesisPredispositionPrevention educationPrevention strategyProductionProgram DevelopmentPropertyProteinsReactive Oxygen SpeciesResearchResearch PersonnelRoleRouteSeminal PlasmaSeminal fluidSequence AnalysisSexually Transmitted DiseasesSourceSuperoxidesSurfaceTherapeutic immunosuppressionVariantVesiclebasedisease transmissiondisorder preventionimmunoregulationimprovedinsightlymphocyte proliferationneutrophilpathogenprogramsreceptorreproductivesperm celltransmission process
中文摘要
描述(申请人提供):人类精浆含有多种免疫抑制因子,可下调女性生殖道的天然免疫力。这些免疫抑制因子的作用是保护精子免受女性免疫系统的侵害。然而,免疫抑制效应可能会增加女性生殖道对包括艾滋病毒在内的性传播疾病感染的易感性。我们实验室的初步研究发现,Galectin-3存在于前列腺体上,即精浆中抑制白细胞功能的膜性小泡上。值得注意的是,Galectin-3受体表达在白细胞上,Galectin-3具有免疫调节特性,Galectin-3在病原体-宿主细胞相互作用中发挥作用。因此,我们假设Galectin-3有助于前列腺体的免疫抑制特性,并促进性传播感染。本项目的总体目标是研究Galectin-3在前列腺体中与免疫抑制相关的功能。该项目的目的是通过微序列分析确定前列腺体中Galectin-3的特异性结合配体,并研究Galectin-3在前列腺体中的定位和功能。用免疫电子显微镜和流式细胞术研究Galectin-3及其配体在前列腺体上的表面定位。Galectin-3在前列腺体-白细胞黏附中的作用将通过荧光显微镜和流式细胞仪进行评估。功能分析将研究Galectin-3在前列腺体介导的抑制淋巴细胞增殖和中性粒细胞产生活性氧(ROS)中的作用。涉及截短的Galectin-3变体的前列腺体Galectin-3功能的潜在调节机制将被研究。我们预计,对精浆中免疫抑制因子及其对女性生殖道天然免疫和获得性免疫的影响的深入了解将对STD/HIV的传播和发病机制提供重要的见解,并将对未来的STD预防策略产生重大影响。
英文摘要
DESCRIPTION (provided by applicant): Human seminal plasma contains multiple immunosuppressive factors that down-regulate innate immunity in the female reproductive tract. These immunosuppressive factors function to protect spermatozoa from the female immune system. However, the immunosuppressive effects potentially increase susceptibility of the female genital tract to infection by sexually transmitted diseases, including HIV. Preliminary studies from our laboratory identified galectin-3 on prostasomes, membranous vesicles in seminal plasma that inhibit leukocyte function. Significantly, galectin-3 receptors are expressed on leukocytes, galectin-3 exhibits immunomodulatory properties, and galectin-3 functions in pathogen-host cell interactions. Therefore, we hypothesize that galectin-3 contributes to the immunosuppressive properties of prostasomes and facilitates sexually transmitted infections. The overall goal of the current project is to investigate galectin-3 function in prostasomes with specific regard to immunosuppression. The aims of the proposed project are to identify the specific galectin-3 binding ligands in prostasomes by microsequence analysis and to investigate the localization and function of galectin-3 in prostasomes. Surface localization of galectin-3 and its ligands on prostasomes will be investigated using immunoelectron microscopy and flow cytometry. The role of galectin-3 in prostasome-leukocyte adhesion will be evaluated using fluorescence microscopy and flow cytometry. Functional assays will investigate the role of galectin-3 in prostasome-mediated inhibition of lymphocyte proliferation and of reactive oxygen species (ROS) production in neutrophils. A potential regulatory mechanism of galectin-3 function in prostasomes involving a truncated galectin-3 variant will be investigated. We anticipate that improved understanding of immunosuppressive factors in seminal plasma and their effects on innate and adaptive immunity in the female genital tract will provide significant insights into STD/HIV transmission and pathogenesis and will have significant implications for future STD prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of galectin-3 in genital tract immunosuppression
-
批准号:6958205
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2005
-
负责人:ALAN B DIEKMAN
-
依托单位:
Role of galectin-3 in genital tract immunosuppression
-
批准号:7424072
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2005
-
负责人:ALAN B DIEKMAN
-
依托单位:
Role of galectin-3 in genital tract immunosuppression
-
批准号:7106513
-
项目类别:
-
资助金额:$23.73万
-
财政年份:2005
-
负责人:ALAN B DIEKMAN
-
依托单位:
Role of GPI-Anchored CD52 Glycoprotein in Sperm Function
-
批准号:6652505
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2002
-
负责人:ALAN B DIEKMAN
-
依托单位:
Role of GPI-Anchored CD52 Glycoprotein in Sperm Function
-
批准号:6542537
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2002
-
负责人:ALAN B DIEKMAN
-
依托单位:
RECOMBINANT ANTIBODIES AS INTRA VAGINAL SPERMICIDES
-
批准号:2421477
-
项目类别:
-
资助金额:$8.8万
-
财政年份:1997
-
负责人:ALAN B DIEKMAN
-
依托单位:
HUMAN SPERM ZONA BINDING PROTEIN
-
批准号:2196430
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1996
-
负责人:ALAN B DIEKMAN
-
依托单位:
海外基金